Lv1
70 积分 2025-01-02 加入
Improved immune responses in lung cancer with radiotherapy and immune checkpoint inhibition
8个月前
已关闭
From Rarity to Reality: Osimertinib's Promising Horizon in Treating Uncommon EGFR Mutations in Non-Small Cell Lung Cancer
9个月前
已完结
Perioperative Immune Checkpoint Inhibition in Early-Stage Non–Small Cell Lung Cancer
9个月前
已完结
皖公网安备34019202002308
